SCHEMBL24779795

SCHEMBL24779795

Cc1c(Cl)cnn(CC(=O)c2ccc(Cl)cc2)c1=O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.77
ALDH1A1 P00352 8/20 0.77
HTT P42858 5/20 0.77
SMN1; SMN2 Q16637 5/20 0.77
S1PR4 O95977 4/20 0.77
S1PR1 P21453 4/20 0.77
MITF O75030 3/20 0.77
TP53 P04637 1/20 0.77
NPSR1 Q6W5P4 5/20 0.62
POLB P06746 2/20 0.62
RAB9A P51151 9/20 0.58
NPC1 O15118 7/20 0.58
KMT2A Q03164 3/20 0.58
MEN1 O00255 2/20 0.58
LMNA P02545 3/20 0.50
MGAM O43451 2/20 0.49
AMY1A P0DUB6 2/20 0.49
GAA P10253 2/20 0.49
SI P14410 2/20 0.49
MGAM2 Q2M2H8 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31172052 0.87 ALDH1A1 (1.00) MAPTALDH1A1HTTSMN1; SMN2S1PR4
SCHEMBL31172053 0.82 ALDH1A1 (0.80) MAPTALDH1A1HTTSMN1; SMN2S1PR4
SCHEMBL29451310 0.82 ALDH1A1 (0.53) MAPTALDH1A1HTTSMN1; SMN2S1PR4
SCHEMBL24779603 0.81 MAPT (0.69) MAPTALDH1A1HTTSMN1; SMN2S1PR4
SCHEMBL24780884 0.77 MAPT (0.63) MAPTALDH1A1HTTSMN1; SMN2S1PR4
SCHEMBL24780120 0.76 ALDH1A1 (0.74) MAPTALDH1A1HTTSMN1; SMN2S1PR4
SCHEMBL30158331 0.76 ALDH1A1 (0.70) MAPTALDH1A1HTTSMN1; SMN2S1PR4
SCHEMBL29451328 0.75 MEN1 (0.51) MAPTALDH1A1HTTSMN1; SMN2S1PR4
SCHEMBL27514400 0.75 MAPT (0.55) MAPTALDH1A1HTTSMN1; SMN2S1PR4
SCHEMBL31172061 0.75 ALDH1A1 (0.70) MAPTALDH1A1HTTSMN1; SMN2S1PR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022258992-A1 PYRIDAZINONES FOR THE TREATMENT OR PREVENTION OF HYPERTENSION UNIVERSITETET I OSLO (NO) 2022-12-15 WO disclosed